HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

WONOEP appraisal: Molecular and cellular biomarkers for epilepsy.

Abstract
Peripheral biomarkers have myriad potential uses for treatment, prediction, prognostication, and pharmacovigilance in epilepsy. To date, no single peripheral biomarker has demonstrated proven effectiveness, although multiple candidates are in development. In this review, we discuss the major areas of focus including inflammation, blood-brain barrier dysfunction, redox alterations, metabolism, hormones and growth factors.
AuthorsLauren E Walker, Damir Janigro, Uwe Heinemann, Raili Riikonen, Christophe Bernard, Manisha Patel
JournalEpilepsia (Epilepsia) Vol. 57 Issue 9 Pg. 1354-62 (09 2016) ISSN: 1528-1167 [Electronic] United States
PMID27374986 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)
CopyrightWiley Periodicals, Inc. © 2016 International League Against Epilepsy.
Chemical References
  • Biomarkers
  • Intercellular Signaling Peptides and Proteins
Topics
  • Animals
  • Biomarkers (metabolism)
  • Blood-Brain Barrier (physiopathology)
  • Epilepsy (genetics, metabolism)
  • Humans
  • Inflammation (metabolism)
  • Intercellular Signaling Peptides and Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: